WEKO3
アイテム
A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
https://tokushima-u.repo.nii.ac.jp/records/2008019
https://tokushima-u.repo.nii.ac.jp/records/2008019298de822-0175-428c-8e37-830cfdec2ac3
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
cdr_16_9_83.pdf (334 KB)
|
.png)
|
| Item type | 文献 / Documents(1) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2020-12-14 | |||||||||||||||||||||
| アクセス権 | ||||||||||||||||||||||
| アクセス権 | open access | |||||||||||||||||||||
| 資源タイプ | ||||||||||||||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||||||||||||||
| 資源タイプ | journal article | |||||||||||||||||||||
| 出版社版DOI | ||||||||||||||||||||||
| 関連識別子 | https://doi.org/10.1007/s11892-016-0772-0 | |||||||||||||||||||||
| 関連名称 | 10.1007/s11892-016-0772-0 | |||||||||||||||||||||
| 出版タイプ | ||||||||||||||||||||||
| 出版タイプ | VoR | |||||||||||||||||||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||||||||||||||||
| タイトル | ||||||||||||||||||||||
| タイトル | A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes | |||||||||||||||||||||
| 著者 |
King, Allen B.
× King, Allen B.
× 黒田, 暁生
WEKO
522
× 松久, 宗英
WEKO
415
× Hobbs, Todd
|
|||||||||||||||||||||
| 抄録 | ||||||||||||||||||||||
| 内容記述 | Dosing guidelines for patients with type 1 diabetes using continuous subcutaneous insulin infusion (CSII), which are historically based on clinical experience and retrospective studies of patients consuming an American diet, recommend that basal insulin should represent approximately 50 % of the total daily dose (TDD). Recent prospective studies in the USA and Japan conclude that the more appropriate proportion is closer to 30–40 % of TDD. In addition, currently used formulas for calculating the carbohydrate-to-insulin ratio (CIR) and correction factor (CF) may lead to underdosing of bolus insulin by as much as 12.8–50 % for a hypothetical patient. The discrepancies between traditional formulas and data from newer studies can be accounted for by the more rigorous design of the newer studies (e.g., prospective design, controlled diets, meal omission, and frequent glucose monitoring). International differences in diet composition may also be important to consider when developing dosing recommendations for CSII. | |||||||||||||||||||||
| キーワード | ||||||||||||||||||||||
| 主題 | Type 1 diabetes | |||||||||||||||||||||
| キーワード | ||||||||||||||||||||||
| 主題 | Insulinpump | |||||||||||||||||||||
| キーワード | ||||||||||||||||||||||
| 主題 | Dosingformulas | |||||||||||||||||||||
| キーワード | ||||||||||||||||||||||
| 主題 | Insulin-dosing guidelines | |||||||||||||||||||||
| キーワード | ||||||||||||||||||||||
| 主題 | Continuous subcutaneous insulin infusion | |||||||||||||||||||||
| 書誌情報 |
en : Current Diabetes Reports 巻 16, 号 9, p. 83, 発行日 2016-07-25 |
|||||||||||||||||||||
| 収録物ID | ||||||||||||||||||||||
| 収録物識別子タイプ | ISSN | |||||||||||||||||||||
| 収録物識別子 | 15390829 | |||||||||||||||||||||
| 収録物ID | ||||||||||||||||||||||
| 収録物識別子タイプ | NCID | |||||||||||||||||||||
| 収録物識別子 | AA12628906 | |||||||||||||||||||||
| 出版者 | ||||||||||||||||||||||
| 出版者 | Springer Nature | |||||||||||||||||||||
| 権利情報 | ||||||||||||||||||||||
| 権利情報 | This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. | |||||||||||||||||||||
| EID | ||||||||||||||||||||||
| 識別子 | 322683 | |||||||||||||||||||||
| 言語 | ||||||||||||||||||||||
| 言語 | eng | |||||||||||||||||||||
